SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-010058
Filing Date
2020-03-11
Accepted
2020-03-11 16:08:52
Documents
76
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cala-10k_20191231.htm 10-K 2744637
2 EX-4.3 cala-ex43_373.htm EX-4.3 46434
3 EX-23.1 cala-ex231_7.htm EX-23.1 3090
4 EX-31.1 cala-ex311_8.htm EX-31.1 15661
5 EX-32.1 cala-ex321_6.htm EX-32.1 7610
6 GRAPHIC gbjezjmo2mza000001.jpg GRAPHIC 34163
  Complete submission text file 0001564590-20-010058.txt   9467113

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cala-20191231.xml EX-101.INS 2158031
8 XBRL TAXONOMY EXTENSION SCHEMA cala-20191231.xsd EX-101.SCH 58269
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20191231_cal.xml EX-101.CAL 57683
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20191231_def.xml EX-101.DEF 177959
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20191231_lab.xml EX-101.LAB 465891
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20191231_pre.xml EX-101.PRE 373244
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36644 | Film No.: 20705350
SIC: 2834 Pharmaceutical Preparations